Document is current
Any future updates will be listed below
-
Authors
Wang, Li
Liu, Jiaying
Shang, Yucui
Zhang, Lanxin
Zhang, Muchen
Fu, Di
Cheng, Shu
Xu, Pengpeng
Anegeli, Eurydice
Bousquet, Guilhem
Fang, Ying
Liu, Yu
Zhao, Wei-Li
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82400220, 82130004, 82170178, 82200201, 82070204)
the Science and Technology Commission of Shanghai Municipality (24ZR1446300)
National Key Research and Development Program of China (2022YFC2502600 and 2023YFC3605704)
the Chang Jiang Scholars Program
Shanghai Clinical Research Center for Cell Therapy (23J41900100)
the Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR1032B)
the Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine (DLY201601)
the Multicenter Hematology-Oncology Program Evaluation System
the Collaborative Innovation Center of Systems Biomedicine
the Samuel Waxman Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 10 July 2025
Accepted: 3 December 2025
First Online: 12 January 2026
Declarations
:
: The Hospital Review Board approved the study, and informed consent was obtained following the Declaration of Helsinki. Animals were used according to the ARRIVE guidelines and the protocols approved by the Shanghai Rui Jin Hospital Animal Care and Use Committee.
: Not applicable.
: The authors declare no competing interests.
